Thromboxane A2 Inhibitors has 1 known drug interaction based on U.S. FDA drug labeling data. Notable interactions include combinations with Verteporfin For Injection. Patients taking Thromboxane A2 Inhibitors should inform their healthcare provider of all current medications — including over-the-counter drugs and supplements — to avoid potentially harmful combinations. Data sourced from OpenFDA and the NIH National Library of Medicine.

Total: 1
Moderate: 1

Moderate (1)

Thromboxane A2 Inhibitors + Verteporfin For Injection— Drugs that decrease clotting, vasoconstriction or platelet aggregation could decrease the efficacy of VISUDYNE therapy.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine. For informational purposes only. Always consult your pharmacist or physician.